Search results
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
There’s a New Weight-Loss Drug Called Zepbound. Really? Zepbound?
Slate via Yahoo News· 7 months agoThis week, the world simultaneously got yet another weight-loss drug and a reason to wonder why...
GSK soothes investors by settling first Zantac cancer lawsuit due for US trial
Reuters via Yahoo Finance· 12 months agoGSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug Zantac caused cancer,...
GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link
Reuters via Yahoo Finance· 2 years agoDrugmakers GSK Plc, Pfizer Inc, Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands...
First Zantac cancer risk trial in Calif. postponed five months
Reuters via Yahoo News· 1 year ago(Reuters) -The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer,...
GSK settles another California lawsuit on heartburn drug Zantac
Reuters via Yahoo Finance· 8 months agoGSK on Wednesday said it agreed to settle another lawsuit in California alleging its discontinued...
GSK settles another lawsuit on heartburn drug Zantac in California
Reuters via Yahoo Finance· 3 months agoGSK does not admit to any liability in this settlement with Boyd/Steenvoord, it said on Thursday....
GSK, Sanofi shares rise after U.S. judge dismisses Zantac cancer link lawsuits
Investing.com via Yahoo Finance· 2 years agoBy Scott Kanowsky Investing.com -- Shares in GSK plc (LON:GSK) and Sanofi SA (EPA:SASY) soared on Wednesday after the drugmakers saw tens of thousands of lawsuits involving the heartburn medicine ...
The Differences Between Famotidine and Omeprazole
Verywell Health via Yahoo News· 12 months agoFamotidine (brand name Pepcid) and omeprazole (brand name Prilosec) are popular treatment options for heartburn. Famotidine is a histamine-2 receptor...
First trial over Zantac cancer claims set for November
Reuters via Yahoo Finance· 11 months agoThe first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state court on Nov. 13, a lawyer for plaintiffs in the litigation ...
